1 / 19

Catecholamine Agonists and Antagonists

Catecholamine Agonists and Antagonists. Norepinephrine Alpha 1 & 2 and Beta 1 agonist Epinephrine Alpha 1 & 2 and Beta 1 & 2 agonist Beta 3???? Phenylephrine, Methoxamine Selective alpha 1 agonists Clonidine, Guanfacine, Brimonidine Selective alpha 2 agonists Dobutamine

tierra
Download Presentation

Catecholamine Agonists and Antagonists

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Catecholamine Agonists and Antagonists

  2. Norepinephrine Alpha 1 & 2 and Beta 1 agonist Epinephrine Alpha 1 & 2 and Beta 1 & 2 agonist Beta 3???? Phenylephrine, Methoxamine Selective alpha 1 agonists Clonidine, Guanfacine, Brimonidine Selective alpha 2 agonists Dobutamine Selective beta 1 agonist Isoproterenol Beta 1 & 2 agonist Terbutaline, Albuterol, Ritodrine Selective Beta 2 agonists Tyramine Indirectly acting NE releasing agent Dopamine See DOPAMINE slide Cocaine NE uptake inhibitor Need-to-know Drugs

  3. Directly Acting Agonists • Selective alpha 1 agonists • Phenylephrine, methoxamine • Selective alpha 2 agonists • Clonidine, Brimonidine, guanfacine and guanabenz • Mixed agonists • Norepinephrine (no B-2) and Epinephrine • Selective Beta 1 agonist • Dobutamine • Beta 1 & 2 agonist • Isoproterenol • Selective Beta 2 agonist • Terbutaline, albuterol, ritodrine

  4. Mixed Agonist • Epinephrine at low doses: • Beta-adrenergic action more evident • Epinephrine at high doses: • Alpha mediated constriction of all vessels • Norepinephrine • Agonist ro alphas and beta 1 (not beta 2) • Increases total peripheral resistance and blood pressure • Heart rate may go up or down • “direct effects on ventricular musce not easily masked by baroreceptor reflex” (whatever that means) • Don’t assume balance of SNS and PNS

  5. Indirectly acting sympathomimetics • Elicit effects similar to NE. Read more in syllabus/text • Releasing Agents • Amphetamine and tyramine • Uptake Inhibitors • Cocaine • MAO/COMT inhibitors • Pargyline and entacapone

  6. Questions • What indirect sympathomimetic agent is found in red wine, cheese, soybeans, and avocados? • Tyramine (which causes the release of NE from the nerve terminal) • What are the 5 cardiovascular effects of pure alpha stimulation? • Constriction of vessels • Increased TPR • Reduced flow • Increased BP • Decreased HR (little direct effect on the heart) • What are the cardiovascular effects of pure beta stimulation • Dilation of skeletal muscle vasculature (b2) • Decreased TPR, • increased flow, • decreased BP, • Increased HR (b1)

  7. Clinical Questions • What agents can be used to relieve bronchoconstriction associated with asthma, pulmonary emphysema and bronchitis? • Beta 2s like albuterol or terbutaline • What agents can be used to restore activity to the heart in complete heart block or after cardiac arrest? • Beta 1s like isoproterenol or epinephrine (last ditch effort) • The alpha activity of epinephrine is useful for what conditions? • Hemostasis, anaphylaxis, reducing the diffusion of infiltration anesthetics, and maintaining BP if CO and perfusion are intact • What conditions could be effectively treated by a selective alpha 1 agonist like phenylephrine? • Nasal congestion, and as a mydriatic agent

  8. Clinical Questions • What agents are useful for treating Narcolepsy and minimal brain dysfunction? • Modafinil (new/good) and amphetamines (old/bad) • What drugs are useful for glaucoma? • Specific alpha 2 agonists like Brimonidine (new) • What else are alpha 2 agonists good for? • Treating hypertension and, as of 2007, treatment of ADHD

  9. Dopamine • What are three mechanisms by which Dopamine acts as an administered drug? • Altering release of NE from adrenergic neurons • Interacting with alpha and beta 1 receptors • Interacting with periperal dopamine receptors • What are its effects (low dose/high dose)? • Low doses elicit vasodilation in renal, mesenteric, coronary, and intracerebral vascular beds (alpha dopamine 1 effect) • Slightly higher doses increase heart rate and contractility, particularly contractility. Increases heart O2 consumption LESS than Epi. • At High doses alpha mediated vasoconstriction occurs • Dopamine may be used as an IV to enhance renal perfusion or as a positive inotrope. • What’s better about Dobutamine? • Similar to Dopamine, but has an even better inotropic/chronotropic ratio, so its even better for heart problems. It is a specific Beta 1 agonist.

  10. Adrenoceptor Antagonists 9/25/07

  11. Need-to-Know Drugs • Phenoxybenzamine • Alpha 1 (and some alpha 2) blocker • Phentolamine • Nonselective alpha blocker • Prazosin, Terazosin, Doxazosin • Selective Alpha 1 blockers, very useful • Propranolol, Timolol, Nadolol • Nonselective Beta Blocker • Atenolol, Esmolol • Selective Beta 1 antagonists, very useful • Labetalol • Mixed antagonist (B1 = B2 ≥ A1 > A2)

  12. Usefulness • Which two classes of adrenoceptor antagonists are most clinically useful? • Selective alpha 1 antagonists: Prazosin, Terazosin, doxazosin • Selective Beta 1 antagonists: Metoprolol, Esmolol, Atenolol, Acebutolol, Alprenolol, Betaxolol, Celiprolol

  13. Alpha Blockers • Compare and contrast the three groups of Alpha Receptor Blockers • 1) Phenoxybenzamine- (haloalkylamines) • Irreversible blockade of alpha 1 and 2 receptors through covalent bonds. • May block histamine receptors and neuronal reuptake of catecholamines. • Most important clinical effect is marked vasodilation of both arteries and veins, reducing TPR and BP. Increases blood flow to most vascular beds. • Increases heart rate and contractility through baroreflex, inhibition of neuronal reuptake, and blocking alpha 2 presynaptic receptors (increasing NE). • Long duration, 2-3 days. • Useful in treatment of pheochromocytoma, peripheral vascular disease like Renaud’s, as an adjunct in shock, prostatic hypertrophy. • Many adverse effects including: postural hypotension, tachycardia, arrhythmias, myocardial ischemia, misosis, nasal stuffiness, drowsiness, nausea, and failure to ejaculate.

  14. Alpha Blockers • Compare and contrast the three groups of Alpha Receptor Blockers • 2) Phentolamine (imidazolines) • Reversible inhibition at alpha 1 & 2. Blocks serotonin at high doses • Mostly similar action as Phenoxybenzamine, but also enhances GI motility and secretion through histamine release by mast cells. Contraindicated in patients with gastritis or peptic ulcer. • Much shorter duration • Silimar clinical uses as Phenoxybenzamine

  15. Alpha Blockers • Compare and contrast the three groups of Alpha Receptor Blockers • 3) Prazosin, Terazosin, and Doxazosin (quinazoline derivatives) • Selectively blocks alpha 1 reversibly. • Decreases peripheral vascular resistance, increases flow (vasodilator) and decreases pre-load, but does not induce reflex tachycardia (no alpha 2 activity). • Used for essential hypertension, CHF, BPH • Main side effect is postural hypotension. • Duration: Prazosin 7-10 hours. Terazosin and Doxazosin are more water soluble and last 18-36 hours.

  16. Beta Receptor Blockers • What was the first beta adrenoreceptor antagonist introduced for clinical use in the U.S.? • Propranolol (nonselective beta blocker) • Which isomers, levo or dextro, are more active as beta antagonists? • levo

  17. Beta Blocker Characteristics • Mechanism • Reversible competitive antagonism of Beta receptors • Main Effects • Decrease heart rate, contractility, CO, and conduction velocity, particularly when sympathetic activity is high. • Reduce BP with chronic use, partly due to decreased renal renin release. • Decrease glycogenolysis and lipolysis. • Increase airway resistance (decreased Beta 2) • Reduce intraocular pressure in open angle glaucoma • May have some membrane stabilizing or local anesthetic effect (propranolol) or have a slight intrinsic sympathomimetic activity (partial agonist; pindolol) • Clinical Uses • arrhythmias, angina, HTN, MI, hyperthyroidism, open angle glaucoma, prophylactic migraine treatment, acute dissecticing aortic anneurysm and pheochromocytoma (after alpha antagonists)

  18. Beta Blocker characteristics • Clinical Problems • Heart effects can cause problems in CHF patients and those with conduction disturbances. • Bronchoconstriction. Even selective B1 blockers should be used with caution in asthmatics • Hypoglycemic effect is dangerous in DM type 1 patients. • Side effects include: tiredness, insomnia, depression, nightmares, diarrhea, heartburn, rash, and fever. • Must be discontinued slowly to prevent “beta-blocker withdrawl syndrome” • Selective Beta 1 Blockers • Atenolol and Esmolol (as well as metoprolol, acebutolol, alprenolol, atenolol, betaxolol, and celiprolol (from the chart)) • Selective Beta 2 Blocker • Butoxamine (clinically useless??)

  19. Mixed Antagonists • Examples • Lebtalol or Carvedilol • Mechanism • Competitive blocking of beta receptors and alpha 1 receptor • Some sympathomimetic activity at alpha 2 and Beta 2 • Direct, non-receptor mediated vasodilation (I guess on top of its alpha 1 blocking vasodilation) • May block neuronal reuptake of catecholamines • Clinical Use • Chronic HTN, HTN + Angina, and Ischemic Heart disease • Clinical Problems • May cause excessie hypotension or “paradoxical presser effects,” GI distress, tiredness, sexual dysfunction • Dangerous in asthmatics and CHF patients (like any beta blockers)

More Related